Home › Funds › Siren, L.L.C. › RCUS

Siren, L.L.C. position in RCUS

Arcus Biosciences, Inc. · Health Care

Siren, L.L.C. reported holding 2,420,430 shares of RCUS (Arcus Biosciences, Inc.) in its Q3 2026 13F filing — a position valued at US$62.5M, representing 1.49% of its reported portfolio and ranking #20 among its reported holdings. Siren, L.L.C. has disclosed RCUS holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)2.42M sh
Reported value held$62.52M
Portfolio Weight1.49%
First reportedQ3 2024
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s RCUS position evolved

Siren, L.L.C. first disclosed a stake in RCUS in Q3 2024 at 1,612,077 shares (US$24.6M). The position peaked in Q2 2026 at 2,420,430 shares, worth US$74.6M. Across 9 filings, Siren, L.L.C. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 2,420,430 shares valued at US$62.5M. Notable position changes include a 81% increase in Q3 2025 (shares rose 75% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 1.61M $24.65M New
Q4 2024 1.61M $24.00M Hold
Q1 2025 1.61M $12.65M Hold
Q2 2025 1.61M $13.12M Hold
Q3 2025 2.91M $39.60M Add
Q4 2025 3.01M $71.66M Add
Q1 2026 3.01M $64.95M Hold
Q2 2026 2.42M $74.62M Reduce
Q3 2026 2.42M $62.52M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RCUS and 13F data

RCUS (Arcus Biosciences, Inc.) is a Health Care company. 46 other funds we track also report a position in RCUS — the largest reported positions include GILEAD SCIENCES, INC. (US$811.7M), MONTANOVA CAPITAL, LLC (US$147.3M), SAMLYN CAPITAL, LLC (US$47.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RCUS

All RCUS fund holders →

FAQ

How long has Siren, L.L.C. held RCUS?

Siren, L.L.C. has disclosed RCUS holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Siren, L.L.C.'s current position in RCUS?

As of Q3 2026, Siren, L.L.C. holds 2.42M shares of RCUS (Arcus Biosciences, Inc.), valued at $62.52M, representing 1.49% of its reported portfolio and ranking #20.

Has Siren, L.L.C. been buying or selling RCUS?

In the latest 13F filing (Q3 2026), Siren, L.L.C. held unchanged its position in RCUS. The position peaked in Q2 2026 at 2.42M shares.

Which other funds hold RCUS?

Other major institutional holders of RCUS include GILEAD SCIENCES, INC., MONTANOVA CAPITAL, LLC, SAMLYN CAPITAL, LLC, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.